AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PharmaCyte Biotech, Inc. Director's Dealing 2022

Aug 24, 2022

35351_dirs_2022-08-24_0c2f2180-bae9-4687-81bc-5e04712a52af.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PharmaCyte Biotech, Inc. (PMCB)
CIK: 0001157075
Period of Report: 2022-08-15

Reporting Person: Allen Daniel (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	260000	Indirect